Home » Topics » Regulatory

Regulatory
RSS

SangStat obtains technology to develop smaller ciclosporin capsule

Oct. 16, 2000

Remicade recommended for expanded approval in Europe

Oct. 13, 2000

Shire submits NDA for once-daily Adderall for ADHD

Oct. 13, 2000

FDA approves first and only once-monthly contraceptive for women

Oct. 10, 2000

Ciba Vision and QLT seek to expand Visudyne indication in the E.U.

Oct. 5, 2000

First prescription drug to treat unwanted facial hair introduced in U.S.

Oct. 5, 2000

FDA approves breath-activated device with corticosteroid for asthma

Oct. 5, 2000

Novo Nordisk's liquid Norditropin now available in U.S.

Oct. 5, 2000

BLA supplement filed for alteplase

Oct. 4, 2000

FDA approves cream formulation of Allergan's Tazorac

Oct. 4, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...